Navigation Links
Research Reports Initiation on Medical Supplies Stocks -- OraSure Technologies, TransEnterix, Glaukos, and Tandem Diabetes
Date:4/6/2017

NEW YORK, April 6, 2017 /PRNewswire/ --

Today's research on Stock-Callers.com brings investors' attention back to the Medical Instruments and Supplies industry, which is engaged in the research, development, and production of non-electronic medical, surgical, dental, and veterinary instruments. Four equities have been selected for coverage this morning and they are: OraSure Technologies Inc. (NASDAQ: OSUR), TransEnterix Inc. (NYSE MKT: TRXC), Glaukos Corp. (NYSE: GKOS), and Tandem Diabetes Care Inc. (NASDAQ: TNDM). Learn more about these stocks by downloading their free report at:

http://stock-callers.com/registration

OraSure Technologies  

On Wednesday, shares in Bethlehem, Pennsylvania-based OraSure Technologies Inc. recorded a trading volume of 1.01 million shares, which was above their three months average volume of 887,980 shares. The stock ended the session 2.14% lower at $12.36. The Company's shares have gained 7.01% in the last one month, 38.26% over the previous three months, and 40.77% on an YTD basis. The stock is trading 13.67% above its 50-day moving average and 43.57% above its 200-day moving average. Moreover, shares of OraSure Technologies, which together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the US, Europe, and internationally, have a Relative Strength Index (RSI) of 61.78. The free research report on OSUR is available at:

http://stock-callers.com/registration/?symbol=OSUR


TransEnterix  

Morrisville, North Carolina headquartered TransEnterix Inc.'s stock closed the day 5.31% lower at $1.07. A total volume of 825,331 shares was traded, which was above their three months average volume of 626,240 shares. The Company's shares are trading 16.94% below their 50-day moving average. Additionally, shares of TransEnterix, which focuses on the development and commercialization of surgical robotic systems, have an RSI of 36.33.

On March 22nd, 2017, TransEnterix announced that it has expanded the clinical adoption of the Senhance Robotic Surgical System to include a full range of hernia repair surgeries. The complimentary report on TRXC can be downloaded at:


http://stock-callers.com/registration/?symbol=TRXC


Glaukos  

Shares in San Clemente, California headquartered Glaukos Corp. recorded a trading volume of 396,642 shares. The stock ended yesterday's trading session 2.98% lower at $50.45. The Company's shares have advanced 14.48% in the past month, 47.51% in the previous three months, and 47.08% on an YTD basis. The stock is trading above its 50-day and 200-day moving averages by 10.54% and 37.49%, respectively. Furthermore, shares of Glaukos, which focuses on the development and commercialization of products and procedures designed to treat glaucoma, have an RSI of 59.55.

On March 16th, 2017, Glaukos announced that the Current Procedural Terminology Editorial Panel of the American Medical Association has granted five-year extensions to three Category III CPT codes that describe insertion of aqueous drainage devices into the anterior chamber of the eye using Micro-Invasive Glaucoma Surgery. Visit us today and download our complete research report on GKOS for free at:

http://stock-callers.com/registration/?symbol=GKOS


Tandem Diabetes  

San Diego, California headquartered Tandem Diabetes Care Inc.'s stock finished Wednesday's session 8.00% lower at $1.15. A total volume of 727,343 shares was traded, which was above their three months average volume of 528,800 shares. The Company's shares are trading below their 50-day moving average by 45.12%. Additionally, shares of Tandem Diabetes Care, which designs, develops, and commercializes various products for people with insulin-dependent diabetes in the US, have an RSI of 26.54.

On March 08th, 2017, Tandem Diabetes Care announced plans to implement a new infusion set connector for Tandem insulin pump cartridges and infusion sets - the t:lock™ Connector. The new design reduces the time required to fill the infusion set tubing by approximately 30 seconds and reduces the amount of insulin used in the process by approximately four and a half units.

On March 30th, 2017, research firm Piper Jaffray resumed its 'Neutral' rating on the Company's stock. Get free access to your technical report on TNDM at:

http://stock-callers.com/registration/?symbol=TNDM

Stock Callers: 

Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below. 

SC has not been compensated; directly or indirectly; for producing or publishing this document. 

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email info@stock-callers.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.  

NO WARRANTY 

SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice. 

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

http://stock-callers.com/legal-disclaimer/

CONTACT
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Email: info@stock-callers.com
Phone number: +44-330-808-3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.



'/>"/>
SOURCE Chelmsford Park SA
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Global $10.06 Billion Eubiotics Market Analysis and Trends and Industry Forecast to 2025 - Research and Markets
2. Product Liability Industry and Attorney Hourly Rate Report 2017: Demand for Medical and Healthcare Product Liability Experts to Push Hourly Rates Higher in 2017 - Research and Markets
3. Asia Pacific Industrial Gloves Market Revenue and Volume is Expected to Reach USD 1.25 Billion and 43.07 Billion Pairs by 2025 Respectively: Transparency Market Research
4. Global Market for Medical Device Coatings to Reach $7.9 Billion in 2021: Forecasts for Eight Types of Coatings & Surface Treatment Technologies - Research and Markets
5. Research and Markets - Global Orthopedic Surgical Robots Market to Grow at a CAGR of 46%, 2017-2021 with OMNI, Smith & Nephew, Stryker & THINK Surgical Leading the Way
6. Global Liposuction Devices Market 2017-2025: Increasing Global Obesity Population - Research and Markets
7. China Pharmaceutical Packaging Industry Report 2017-2021: Focus on 4 Foreign Companies & 8 Local Companies - Research and Markets
8. Global Topical Drug Delivery Market to Reach $125.88 Billion by 2021: High Incidence of Burn Injuries, Rising Geriatric Population & Increasing Incidence of Diabetes - Research and Markets
9. One and a Half Day Seminar: Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (Burlingame, CA, United States - July 27-28, 2017) - Research and Markets
10. Research and Markets Has Announced the Launch of their Roche Diagnostics Market Research Portal
11. Global Human Microbiome Market Estimated at CAGR of 21.1% During 2016-2023: Occams Business Research & Consulting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2017)... -- AVACEN Medical (AVACEN) announced that its CE-Marked AVACEN ... with the widespread pain associated with fibromyalgia in the ... Essex, England commented, "I had difficulty ... sleep at all, tremendous pain, with every movement sending ... AVACEN 100] enough, how this has and is helping ...
(Date:9/18/2017)... 18, 2017 EpiVax, Inc. ("EpiVax") ... and immune engineering, today announced a new ... (H7N9) vaccine. ... influenza and presents a challenge for traditional ... to be effective. Using state-of-the-art bioinformatics and molecular ...
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... Arkansas that offers insurance and financial preparation services, is providing an update on ... Rescue organization. , Rock City Rescue is a locally recognized nonprofit that provides ...
(Date:10/13/2017)... , ... October 13, 2017 , ... ... the certification process to promote standards of excellence for the field of eating ... for March 22 – 25, 2018 in Orlando, Florida at the Omni Resort ...
(Date:10/13/2017)... ... 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes in ... the facility as part of a disaster drill on October 3rd. , Apple Rehab ... City Emergency Manager, as well as the Connecticut Long Term Care Mutual Aid ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
(Date:10/13/2017)... ... 2017 , ... “The Journey: From the Mountains to the Mission Field”: the ... in the Philippines. “The Journey: From the Mountains to the Mission Field” is the ... She has taught all ages and currently teaches a class of ladies at her ...
Breaking Medicine News(10 mins):